Wanbury's Tanuku unit successfully completes Quality Inspection by TGA

Wanbury Limited's API manufacturing site at Tanuku, Andhra Pradesh has successfully completed the Quality inspection by the TGA, Therapeutic Goods Administration which is a drug regulatory agency of Australia. GMP certificate once received, will enable Wanbury to ship additional 3 APis.

Wanbury has continued to remain in cGMP compliance and committed for continual improvement.

Other API site of Wanbury received GMP certificate from MFDS (Korean FDA) for its Patalganga site for the inspection conducted in April 2026.

Shares of Wanbury Limited was last trading in BSE at Rs. 256.05 as compared to the previous close of Rs. 259.35. The total number of shares traded during the day was 9838 in over 301 trades.

The stock hit an intraday high of Rs. 260.10 and intraday low of 254.35. The net turnover during the day was Rs. 2527116.00.

Source : Equity Bulls

Keywords

Wanbury INE107F01022 Pharmaceuticals QualityInspection TGA